Sun Pharma Advanced Research jumps 11%, extends 2-day rally as US court clears Sezaby PRV
Shares of Sun Pharma Advanced Research Company (SPARC) surged 11% to Rs 179.5 on the BSE on Wednesday, marking a second consecutive day of gains following a 20% jump in the previous session. The rally comes after a favourable ruling by a U.S. court concerning the Priority Review Voucher (PRV) for SPARC’s drug Sezaby. On…